Join the Lacosamide group to help and get support from people like you.
Lacosamide News
New Indication for Motpoly XR (Lacosamide Extended-Release) Capsules for Primary Generalized Tonic-Clonic Seizures (Adjunctive Treatment)
SILVER SPRING, MD. June 7, 2024/FDA Approvals/ – Today, the U.S. Food and Drug Administration (FDA) approved Aucta Pharmaceuticals Motpoly XR (lacosamide) capsules (100 mg, 150 mg, and 200 mg) for ...
Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy
ATLANTA, Nov. 17, 2020 /PRNewswire/ – UCB, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Vimpat (lacosamide) CV as adjunctive therapy...